Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era

Microbiol Res. 2022 Dec:265:127206. doi: 10.1016/j.micres.2022.127206. Epub 2022 Sep 21.

Abstract

COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to combat COVID-19 pandemic. Considering the fact that the world is facing a major issue of antimicrobial drug resistance, naturally occurring compounds have the potential to achieve this goal. Antimicrobial peptides (AMPs) are naturally occurring antimicrobial agents which are effective against a wide variety of microbial infections. Therefore, the use of AMPs is an attractive therapeutic strategy for the treatment of SARS-CoV-2 infection. This review sheds light on the potential of antimicrobial peptides as antiviral agents followed by a comprehensive description of effective antiviral peptides derived from various natural sources found to be effective against SARS-CoV and other respiratory viruses. It also highlights the mechanisms of action of antiviral peptides with special emphasis on their effectiveness against SARS-CoV-2 infection.

Keywords: Antimicrobial peptide; Antimicrobial resistance; Antiviral peptides; Severe acute respiratory syndrome coronavirus.

Publication types

  • Review

MeSH terms

  • Antimicrobial Peptides
  • Antiviral Agents / pharmacology
  • COVID-19 Drug Treatment*
  • Drug Resistance, Multiple
  • Humans
  • Pandemics
  • SARS-CoV-2*

Substances

  • Antimicrobial Peptides
  • Antiviral Agents